16 results
DEF 14A
CADL
Candel Therapeutics Inc
2 Sep 22
Definitive proxy
8:30am
related person transactions for potential conflict of interest situations and approving all such transactions; and
reviewing quarterly earnings … requirements. We do not believe the retention of, and the work performed by, Aon creates any conflict of interest because Aon performs no other work
8-K
EX-99.1
CADL
Candel Therapeutics Inc
6 Jun 22
Regulation FD Disclosure
8:37am
Medicine, and Director of the Multidisciplinary Pulmonary Oncology Program at NYU Langone Health Conflict of interest disclosure: Nothing to disclose 15 … of Medical Oncology at the Yale Cancer Center and Smilow Cancer Hospital Conflict of interest disclosure: Member of Candel’s Research Advisory Board
10-K
2021 FY
EX-10.12
CADL
Candel Therapeutics Inc
29 Mar 22
Annual report
8:46am
activities, and (ii) serve on boards of directors of companies that are not competitive with the Company, do not otherwise present a conflict of interest
424B4
sxn4zv57xbat4e3
28 Jul 21
Prospectus supplement with pricing info
4:02pm
S-1/A
xrntjx
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.5.3
4rt47i pq0s
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.5.5
03lt6 c5qjlhk
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.5.2
j23ltezlkq1n8yvz8m
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.6
4xbqxewginzxdo25zj
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.5.4
vo29dmnj 09y8
16 Jul 21
IPO registration (amended)
6:07am
S-1
EX-4.2
a2vdze
25 Jun 21
IPO registration
5:28pm
S-1
zhn pcw6f0yb9llk7om
25 Jun 21
IPO registration
5:28pm
DRS/A
sj32qe 80mqprv
31 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next